Merck, Takeda Unit Beat Off-Label FCA Kickbacks Suit
A California federal judge tossed a whistleblower's allegations that Merck and Co. and two other drugmakers violated the False Claims Act by offering doctors kickbacks to prescribe their blood-thinning drugs, saying...To view the full article, register now.
Already a subscriber? Click here to view full article